Defects of MSH2 are implicated in the development of lymphoblastic lymphomas in humans and mice, and are associated with the aberrant expression of the LMO2 (LIM domain only 2) gene [28], encoding a transcription factor which has a central and crucial role in hematopoietic development and neoplastic transformation. The gene discussed is LMO2; the disease is lymphoblastic lymphoma.